Meprin en es it fr

Meprin Brand names, Meprin Analogs

Meprin Brand Names Mixture

  • No information avaliable

Meprin Chemical_Formula


Meprin RX_link

No information avaliable

Meprin fda sheet

Meprin msds (material safety sheet)

Meprin Synthesis Reference

No information avaliable

Meprin Molecular Weight

309.469 g/mol

Meprin Melting Point

< 25 oC

Meprin H2O Solubility

Soluble as HCl salt

Meprin State


Meprin LogP


Meprin Dosage Forms

Tablets (oral, 1 mg)

Meprin Indication

Used for the symptomatic treatment of parkinsonism.

Meprin Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meprin Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meprin side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meprin Patient Information

Meprin Organisms Affected

Humans and other mammals